TSH: what your result means.

Thyroid-stimulating hormone (TSH) is the pituitary's control signal to the thyroid and the single most sensitive screening test for thyroid dysfunction. When the thyroid under- or over-performs, TSH moves first, often before symptoms are recognised.

Why TSH matters

Thyroid dysfunction affects energy, weight, mood, heart rhythm and lipids, and its symptoms are easily misattributed to stress or ageing. Because TSH shifts before free hormone levels leave range, it catches subclinical dysfunction at the stage where monitoring or simple treatment prevents progression.

Associated risks when out of range: Hypothyroidism (high). Hyperthyroidism (low/very low).

What the clinical evidence shows

The evidence base behind how the HodieLabs Evidence-Based Clinical Library interprets TSH, from randomised trials, prospective cohorts and genetic (Mendelian randomisation) studies. Full citations in the reference list below.

• Colorado thyroid disease prevalence study (Canaris et al. Archives of Internal Medicine 2000): 9.5% of ~25,000 adults had an elevated TSH, the large majority undiagnosed. Subclinical thyroid dysfunction is common and routinely missed without screening.
• Individual-participant meta-analysis (Rodondi et al. JAMA 2010): subclinical hypothyroidism with TSH ≥10 mIU/L was associated with significantly increased coronary heart disease events and mortality, establishing the threshold where risk becomes clinically meaningful.
• TRUST trial (Stott et al. NEJM 2017): levothyroxine gave no symptom benefit in older adults with mildly elevated TSH. Evidence-based practice treats clear dysfunction, and monitors rather than medicates borderline results.

Evidence-based reference ranges

The HodieLabs Evidence-Based Clinical Library interprets TSH against published clinical authority standards, never arbitrary "optimal" ranges. Measured in mIU/L:

Clinical interpretation

• TSH has a circadian rhythm. Highest in early morning, lowest in afternoon. Standardise timing.
• Biotin supplements can interfere with TSH immunoassays. Washout period depends on dose and assay platform: 8 hours may suffice for 5–10 mg doses, but up to 72 hours may be needed for high-dose biotin therapy or low-threshold assay platforms (ADLM/AACC guidance).
• Observational longevity target: TSH 1.0–2.5 mIU/L has been discussed in preventive medicine literature, but ATA/AACE note there are virtually no clinical outcome data supporting treatment of non-pregnant adults with TSH 2.5–4.5 mIU/L. Subclinical hypothyroidism below 10 mIU/L should be individualised, not universally labelled as non-optimal.
• The Hodie Reference Range (0.4–4.0 mIU/L) reflects the ATA diagnostic reference. The 1.0–2.5 observational target is noted for context only and should be clearly separated from diagnostic thresholds.

What improves it: the evidence-based levers

• TSH is the first-line thyroid screen, if abnormal, check Free T4 and Free T3
• Subclinical hypothyroidism (TSH 4–10 with normal FT4) warrants monitoring every 6–12 months

Recommended testing frequency: Annual, as part of a comprehensive panel. Single markers are always interpreted in context.

How TSH testing works at HodieLabs

TSH is measured in every Health Blueprint at our Melbourne Preventative Health & Longevity Clinic, interpreted by a doctor against the guideline-cited ranges above and tracked over time through your HodieLabs membership.

References

1. Canaris GJ, et al. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526–534.
2. Rodondi N, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304:1365–1374.
3. Stott DJ, et al. Thyroid hormone therapy for older adults with subclinical hypothyroidism (TRUST). N Engl J Med. 2017;376:2534–2544.
4. Jonklaas J, et al. Guidelines for the treatment of hypothyroidism (American Thyroid Association). Thyroid. 2014;24:1670–1751.

This page is general information from the HodieLabs Evidence-Based Clinical Library, not medical advice. Speak with your GP about what testing and care is appropriate for you.